KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Exelixis (EXEL) Invested Capital (2016 - 2026)

Historic Invested Capital for Exelixis (EXEL) over the last 17 years, with Q1 2026 value amounting to $2.2 billion.

  • Exelixis' Invested Capital fell 369.32% to $2.2 billion in Q1 2026 from the same period last year, while for Jan 2026 it was $2.2 billion, marking a year-over-year decrease of 369.32%. This contributed to the annual value of $2.2 billion for FY2026, which is 369.32% down from last year.
  • As of Q1 2026, Exelixis' Invested Capital stood at $2.2 billion, which was down 369.32% from $2.2 billion recorded in Q4 2025.
  • Exelixis' 5-year Invested Capital high stood at $2.6 billion for Q1 2023, and its period low was $2.0 billion during Q3 2025.
  • For the 5-year period, Exelixis' Invested Capital averaged around $2.3 billion, with its median value being $2.3 billion (2023).
  • In the last 5 years, Exelixis' Invested Capital soared by 2002.23% in 2022 and then crashed by 1671.64% in 2024.
  • Over the past 5 years, Exelixis' Invested Capital (Quarter) stood at $2.5 billion in 2022, then fell by 9.02% to $2.3 billion in 2023, then grew by 0.51% to $2.3 billion in 2024, then decreased by 5.04% to $2.2 billion in 2025, then increased by 0.03% to $2.2 billion in 2026.
  • Its Invested Capital was $2.2 billion in Q1 2026, compared to $2.2 billion in Q4 2025 and $2.0 billion in Q3 2025.